Phospho-Akt (Ser473) (D9E) Rabbit Monoclonal Antibody and 4 more items

The University of Virginia awarded contract A207_PO-0462198 to Cell Signaling Technology Inc. on July 25, 2026, for the procurement of monoclonal antibodies used in cellular and molecular research applications. The contract encompasses five distinct antibody products with a cumulative value of $1,823.40. The line items include Phospho-Akt (Ser473) (D9E) Rabbit Monoclonal Antibody ($401.40), Phospho-p44/42 Mitogen-Activated Protein Kinase (Erk1/2) (Thr202/Tyr204) (D13.14.4E) Rabbit Monoclonal Antibody ($397.80), Akt (pan) (40D4) Mouse Monoclonal Antibody ($313.20), p44/42 MAPK (Erk1/2) (137F5) Rabbit Monoclonal Antibody ($313.20), and Phospho-Akt (Thr308) (D25E6) Rabbit Monoclonal Antibody ($397.80). All products are ordered in a quantity of one unit each.

All materials under this contract are to be delivered to Brandon Ganzon Velasco at the University of Virginia in Virginia. The antibodies procured through this award are research-grade reagents commonly utilized in biochemical and cell signaling pathway studies, particularly for applications involving protein phosphorylation analysis and signal transduction research. The contract represents a routine procurement of specialized laboratory supplies supporting the institution's research operations.